ArticleJournal of hematology & oncology2023

Novel CD19-specific γ/δ TCR-T cells in relapsed or refractory diffuse large B-cell lymphoma.

Chenggong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.